Apremilast

Details

Files

Generic Name:

Apremilast

Project Status:

Complete

Therapeutic Area:

Arthritis, psoriatic

Manufacturer:

Celgene

Call for patient/clinician input open:

March 31, 2015

Brand Name:

Otezla

Project Line:

Reimbursement Review

Project Number:

SR0437-000

Call for patient/clinician input closed:

May 21, 2015

NOC Status at Filing:

Pre NOC

Submission Type:

Initial

Indications:

Arthritis, psoriatic

Recommendation Type:

List with criteria/condition

Final Recommendation:

December 17, 2015

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : March 31, 2015